Explore the Coronary CTA Advantage

Traditionally, CAD diagnosis has involved various noninvasive tests (e.g., Stress EKG, PET, Stress Echo, and Myocardial Perfusion Imaging [MPI] such as SPECT/PET). While these tests can offer valuable information, they primarily detect indirect markers of disease, which may sometimes lead to diagnostic uncertainty.

Coronary CTA, however, provides direct anatomical visualization of the coronary arteries, enabling a more precise assessment of CAD. This direct visualization helps reduce the risk of false negative and false positive diagnostic results, which can occur up to 30% and 50% of the time respectively with other noninvasive tests.1,2,3

why ccta hero image
The Frontline Strategy for Suspected CAD: CCTA + Heartflow
A new level of diagnostic accuracy and efficiency enabled by the Heartflow AI platform, for more decisive diagnoses of suspected CAD.
Guideline-Recommended Care
Recognized as a Class 1A recommendation per the ACC/AHA Chest Pain Guidelines, CCTA is the preferred modality for assessing suspected CAD in intermediate-risk patients with no known disease.4
Superior Diagnostic Performance
CCTA has demonstrated a significant improvement in accuracy compared to other non-invasive methods for detecting CAD.2
Actionable Insights
CCTA + Heartflow diagnostic testing strategies have been prospectively evaluated in large clinical trials, realizing significant reductions in cardiac-related events while improving preventative medication utilization rates.

Why Choose Coronary CTA?
Accurate. Predictive. Safe.

Superior Diagnostic Performance5
Superior Diagnostic Performance<sup>5</sup>
Efficient and Actionable Insights6
Efficient and Actionable Insights<sup>6</sup>

Less Patient Radiation Exposure

99Tc SPECT7
12.4
mSv
Invasive Coronary
Antiography
with PCI8
6.8
mSv
18F PET7
6.3
mSv
CCTA8
4.1
mSv

Get to a Diagnosis and
Treatment Decision Faster
With CCTA + Heartflow

As the recommended first test for patients with stable chest pain, CCTA + Heartflow FFRCT provides a faster care pathway.

Learn More

Suspected CAD Patient
Guideline
 Recommended
 Pathway
Standard Pathway
CCTA + Heartflow
1A
CCTA
2A
FFRCT
90 minutes
CCTA Scan
FFRCT <.80
Left Main Disease
3-Vessel-Disease
Diagnostic Cath, PCI, or CABG as indicated
Stress Testing
1B
Stress Tests
Weeks / Months
Stress Test
Guideline Directed Medical Therapy
Diagnostic Cath only if symptoms not resolved, or
 PCI or CABG
 as indicated

CTA gives us the information that we were hoping to get from stress testing in a much more accurate and reproducible way the first time.

Dr. Praikh,

Cardiolgoist with NewYork-Presbyterian

Hear How Physicians Are Transforming Their
Cardiac Care Pathway with CCTA + Heartflow

play video pause video
turn on sound turn off sound
download transcript
Current CAD Diagnosis Treatment Paradigms in the Guidelines with Dr. James Udelson, MD
play video pause video
turn on sound turn off sound
download transcript
Identifying Patients That Can Benefit From the CCTA and FFRct Pathway with Dr. Matthew Budoff, MD
Discover how you can use Heartflow to advance your approach to coronary artery disease diagnosis, treatment and management.